Compounds > plerixafor
Page last updated: 2024-08-24

plerixafor and Carcinogenesis

plerixafor has been researched along with Carcinogenesis in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Barwick, B; Boise, L; Chen, HR; Chen, J; Dong, JT; Fu, C; Kowalski, J; Kucuk, O; Li, M; Li, X; Li, Y; Osunkoya, AO; Qian, WP; Vertino, PM; Wu, D; Wu, Q; Xia, S; Xie, L; Yang, L; Zhang, B; Zhao, Y; Zhou, W1
Chen, LP; Cui, WQ; Hu, XM; Shen, W; Xu, H; Yang, W; Zhang, H; Zhang, HL1
Fujita, K; Hatano, K; Kaneda, Y; Murakami, K; Nagahara, A; Nakai, Y; Nakayama, M; Nimura, K; Nonomura, N; Tsuchiya, M; Uemura, M; Yamaguchi, S1
Ahn, SH; Cha, W; Jung, YH; Kim, BH; Kim, KH; Lee, DY; Sung, MW1
Braun, F; Burger, M; Catusse, J; Kayser, G; Reichardt, W; Taromi, S; von Elverfeldt, D; Weber, WA; Zeiser, R1

Other Studies

5 other study(ies) available for plerixafor and Carcinogenesis

ArticleYear
Acetylation of KLF5 maintains EMT and tumorigenicity to cause chemoresistant bone metastasis in prostate cancer.
    Nature communications, 2021, 03-17, Volume: 12, Issue:1

    Topics: Acetylation; Animals; Antineoplastic Combined Chemotherapy Protocols; Benzylamines; Bone Neoplasms; Carcinogenesis; Cell Line, Tumor; Cyclams; Docetaxel; Epithelial-Mesenchymal Transition; Humans; Interleukin-11; Kruppel-Like Transcription Factors; Male; Mice; Mutation; Osteogenesis; Prostatic Neoplasms, Castration-Resistant; Receptors, CXCR4; Signal Transduction; Transforming Growth Factor beta

2021
Chemokine receptor CXCR4 regulates CaMKII/CREB pathway in spinal neurons that underlies cancer-induced bone pain.
    Scientific reports, 2017, 06-21, Volume: 7, Issue:1

    Topics: Animals; Benzylamines; Bone Neoplasms; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cancer Pain; Carcinogenesis; Chemokine CXCL12; Cyclams; Cyclic AMP Response Element-Binding Protein; Estrenes; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds; Humans; Injections, Spinal; Membrane Glycoproteins; Neuroglia; Neurons; Pyrrolidinones; Rats; Receptors, CXCR4; RNA, Small Interfering; Signal Transduction; Spinal Cord

2017
Residual prostate cancer cells after docetaxel therapy increase the tumorigenic potential via constitutive signaling of CXCR4, ERK1/2 and c-Myc.
    Molecular cancer research : MCR, 2013, Volume: 11, Issue:9

    Topics: Animals; Antineoplastic Agents; Benzylamines; Carcinogenesis; Cell Line, Tumor; Cyclams; Disease Models, Animal; Docetaxel; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds; Humans; Male; MAP Kinase Signaling System; Mice, Nude; Mice, SCID; Neoplasm, Residual; Prostatic Neoplasms; Proto-Oncogene Proteins c-myc; Receptors, CXCR4; Signal Transduction; Taxoids

2013
Antitumor effect of CXCR4 antagonist AMD3100 on the tumorigenic cell line of BHP10-3 papillary thyroid cancer cells.
    Head & neck, 2016, Volume: 38, Issue:10

    Topics: Animals; Benzylamines; Carcinogenesis; Carcinoma, Papillary; Cell Line, Tumor; Cell Proliferation; Cyclams; Female; Flow Cytometry; Heterocyclic Compounds; Humans; Immunohistochemistry; Mice; Mice, Nude; Receptors, CXCR4; Thyroid Cancer, Papillary; Thyroid Neoplasms

2016
CXCR4 antagonists suppress small cell lung cancer progression.
    Oncotarget, 2016, Dec-20, Volume: 7, Issue:51

    Topics: Animals; Benzylamines; Carcinogenesis; Cell Line, Tumor; Cell Movement; Cisplatin; Cyclams; DNA-Binding Proteins; Drug Resistance, Neoplasm; Etoposide; Heterocyclic Compounds; Humans; Lung Neoplasms; Mice; Mice, Knockout; Neoplasm Metastasis; Nuclear Proteins; Peptides; Receptors, CXCR4; Small Cell Lung Carcinoma; Xenograft Model Antitumor Assays

2016